Literature DB >> 10398638

Clinical evidence: glycaemic control in diabetes.

W H Herman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10398638      PMCID： PMC1116194          DOI： 10.1136/bmj.319.7202.104

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  M I Harris; K M Flegal; C C Cowie; M S Eberhardt; D E Goldstein; R R Little; H M Wiedmeyer; D D Byrd-Holt
Journal:  Diabetes Care       Date:  1998-04       Impact factor: 19.112

2.  Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial.

Authors: 
Journal:  Diabetes Care       Date:  1996-03       Impact factor: 19.112

3.  The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.

Authors: 
Journal:  Diabetes       Date:  1996-10       Impact factor: 9.461

4.  Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes.

Authors:  P H Wang; J Lau; T C Chalmers
Journal:  Lancet       Date:  1993-05-22       Impact factor: 79.321

5.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

6.  Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years.

Authors:  P Reichard; B Berglund; A Britz; I Cars; B Y Nilsson; U Rosenqvist
Journal:  J Intern Med       Date:  1991-08       Impact factor: 8.989

7.  Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial.

Authors: 
Journal:  Ann Intern Med       Date:  1996-02-15       Impact factor: 25.391

8.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

Authors:  Y Ohkubo; H Kishikawa; E Araki; T Miyata; S Isami; S Motoyoshi; Y Kojima; N Furuyoshi; M Shichiri
Journal:  Diabetes Res Clin Pract       Date:  1995-05       Impact factor: 5.602

9.  The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus.

Authors:  P Reichard; B Y Nilsson; U Rosenqvist
Journal:  N Engl J Med       Date:  1993-07-29       Impact factor: 91.245

10.  Hypoglycaemic episodes during intensified insulin treatment: increased frequency but no effect on cognitive function.

Authors:  P Reichard; A Berglund; A Britz; S Levander; U Rosenqvist
Journal:  J Intern Med       Date:  1991-01       Impact factor: 8.989
  10 in total
  4 in total

1.  UK's diagnostic criteria for diabetes are different from US's.

Authors:  E S Kilpatrick
Journal:  BMJ       Date:  1999-10-02

2.  Glycaemic control of type 2 diabetic patients on follow up at hospital universiti sains malaysia.

Authors:  M Eid; M Mafauzy; Ar Faridah
Journal:  Malays J Med Sci       Date:  2003-07

3.  Evaluation of adverse events of oral antihyperglycemic monotherapy experienced by a geriatric population in a real-world setting: a retrospective cohort analysis.

Authors:  Carl V Asche; Carrie McAdam-Marx; Laura Shane-McWhorter; Xiaoming Sheng; Craig A Plauschinat
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

4.  Oxidative stress and glycaemic control in type 2 diabetic patients in enugu, South-East Nigeria.

Authors:  Ej Ikekpeazu; Ee Neboh; Fe Ejezie; Md Ibegbu; Ie Ike
Journal:  Ann Med Health Sci Res       Date:  2011-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.